Literature DB >> 22408221

Perianal actinomycosis: a case study of this rare infection associated with nicorandil usage.

D J Ablett1, J R Wylie, M S Berlansky.   

Abstract

Perianal actinomycosis infection is a very rare occurrence and is challenging to diagnose. Nicorandil is a potassium channel agonist, which is used in the treatment of ischaemic heart disease. Its usage is associated with perianal ulceration and delayed surgical wound healing. We report a case of actinomycosis complicating a chronic perianal ulcer, which was associated with long-term nicorandil usage. It raised the suspicion of malignancy and required over six months of antimicrobial treatment to achieve satisfactory healing. Perianal actinomycosis results in chronic infection which spreads across tissue planes and can resemble an ulcerated malignancy. Nicorandil usage can result in perianal ulceration and produces conditions which are conducive to actinomycosis infection. In such cases, nicorandil therapy should be discontinued, if possible, and long-term systemic antibiotics form the mainstay of treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22408221     DOI: 10.1258/smj.2011.011277

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  3 in total

Review 1.  Mycotic and Bacterial Infections.

Authors:  Phillip M Duldulao; Adrián E Ortega; Xavier Delgadillo
Journal:  Clin Colon Rectal Surg       Date:  2019-09-06

Review 2.  Nicorandil-induced ulcerations: a 10-year observational study of all cases spontaneously reported to the French pharmacovigilance network.

Authors:  Valérie Babic; Nadine Petitpain; Claire Guy; Philippe Trechot; Anne Claire Bursztejn; Jean Luc Faillie; Thierry Vial; Jean Luc Schmutz; Pierre Gillet
Journal:  Int Wound J       Date:  2018-05-16       Impact factor: 3.315

3.  Actinomycosis Causing Recurrent Perianal Fistulae.

Authors:  Mariana Ferreira Cardoso; Carla Carneiro; Luís Carvalho Lourenço; Catarina Graça Rodrigues; Sara Folgado Alberto; Ana Alagoa João; Ricardo Rocha; Vasco Geraldes; Ana Costa; Jorge Reis; Vítor Nunes
Journal:  ACG Case Rep J       Date:  2017-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.